 |
 |
Are you thinking of Rasagiline, the TEMPO study recently done using newly diagnosed PWPs who had not been on Sinemet, etc ? It's very similar to Selegiline. I was in the this study in 98/99 and I believe the 6 month open label extension of the study must be over now, with possibly another extension. I think you're right about the amphetamine aspect, but not sure. Don't believe it's on the market yet. I'm assuming that you're inquiring about an MAO B-type Inhibitor for PD rather than an MAO A-type for depression, which is quite different. Charlotte vbn6 wrote: > on Sun, 7 Nov 1999 07:15:15 -0800 > J. R. Bruman wrote: > > >> By the way, a substitute MAO inhibitor, that doesn't metabolize to > amphetamine, is under development<< > > Where, who and when, Joe? > > Victoria Nordli cg -- Charlotte Mancuso *************************************************** For advocacy, medical, and other PD-related material, go to: http://www.onelist.com/subscribe/CurePD-NorCal